Edesa Biotech
EDSA
EDSA
19 hedge funds and large institutions have $507K invested in Edesa Biotech in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
66% less capital invested
Capital invested by funds: $1.5M → $507K (-$993K)
Holders
19
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$52K | |
| 2 | +$16K | |
| 3 | +$10.7K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.32K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.59K |
Top Sellers
| 1 | -$810K | |
| 2 | -$239K | |
| 3 | -$27.5K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$14.2K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$18 |